Several GLS inhibitors have been developed, among which CB-839 is currently undergoing clinical trials as a potent, orally bioavailable GLS-selective inhibitor for the treatment of various cancers, including TNBC, NSCLC, and colon cancer (NCT03057600, NCT03057600, NCT03057600, NCT03057600, NCT03057600, NCT03057600)
Both have proven they can manufacture and distribute peptide therapies at scale
Nassar AH, Sakhel K, Maarouf H, et al
Boosting Glutathione Levels Now that we understand the critical role of glutathione in aging, the next question is how we can boost our glutathione levels naturally
Wondering whether oral antioxidants are worth adding? Book a 299 online dermatologist video consult at Skn Biome
It is made by combining L-Carnitine with propionic acid